Samuel Shaolian

Samuel Shaolian

Chief Executive Officer at
Vascular Medcure, Inc.
Health Technology
Consumer Services

Profile

Samuel M Shaolian was the founder of MiCardia Corp., founded in 2004, where the title held was Chief Technology Officer from 2010 to 2011.
Mr. Shaolian was the founder of Onset Medical Corp., founded in 2003, with the title of Director from 2010 to 2011.
Mr. Shaolian was the founder of Ellipse Technologies, Inc., founded in 2005, serving as Director from 2005 to 2009.
Mr. Shaolian is the founder of ThruFlo Endovascular, Inc., founded in 2022, holding the title of Chief Executive Officer since 2022.
Mr. Shaolian is also the founder of Vertelink Corp.,ValCare Medical, Inc...
Mr. Shaolian is Chief Executive Officer at Vascular Medcure, Inc. since 2018.
Mr. Shaolian is Director at Verdian, Inc. Former jobs include Vice President-Research & Development at Endologix LLC and Vice President-Research & Development at CardioDyne, Inc. Education includes undergraduate and graduate degrees from Tel-Aviv University.

Samuel Shaolian active positions

CompaniesPositionStart
Verdian, Inc.
Director/Board Member -
Founder -
Chief Executive Officer 31/12/2017

Former positions of Samuel Shaolian

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer -
ENDOLOGIX, INC. Chief Tech/Sci/R&D Officer -
Founder 28/06/2010
Founder -
Founder -
See the detail of Samuel Shaolian's experience

Training of Samuel Shaolian

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Verdian, Inc.

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Samuel Shaolian